DiscoverAustralian Prescriber PodcastE165 - Assessing, communicating and managing cardiovascular disease risk
E165 - Assessing, communicating and managing cardiovascular disease risk

E165 - Assessing, communicating and managing cardiovascular disease risk

Update: 2024-06-108
Share

Description

Justin Coleman talks to Garry Jennings, Chief Medical Advisor of the National Heart Foundation of Australia, about his article on the 2023 Australian Guideline for Assessing and Managing Cardiovascular Disease Risk. Garry discusses the updates to the guideline, including the age from which assessment should occur and new risk factors considered, and he gives some tips for communicating cardiovascular disease risk to patients. Read the full article by Garry and his co-authors in Australian Prescriber. 

Comments (1)

Marziyeh Badakhsh

how can I found the transcripts of pascats?

Oct 4th
Reply
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
E178 – Reflections on community antimicrobial prescribing in Australia

E178 – Reflections on community antimicrobial prescribing in Australia

2024-12-0918:17

E177 - Inhaler device selection for people with asthma or chronic obstructive pulmonary disease

E177 - Inhaler device selection for people with asthma or chronic obstructive pulmonary disease

2024-11-2518:21

E176 - Managing medicine shortages

E176 - Managing medicine shortages

2024-11-1118:22

E175 - Pharmacological management of polycystic ovary syndrome

E175 - Pharmacological management of polycystic ovary syndrome

2024-10-2816:16

E174 - Achieving safe medication management during transitions of care from hospital

E174 - Achieving safe medication management during transitions of care from hospital

2024-10-1421:35

E173 - Management of occupational exposure to blood and body fluids in primary care

E173 - Management of occupational exposure to blood and body fluids in primary care

2024-09-3019:28

E172 - Utility of common investigations for suspected inflammatory arthritis in adults

E172 - Utility of common investigations for suspected inflammatory arthritis in adults

2024-09-1619:31

E171 - Controversies in the management of community-acquired pneumonia in adults

E171 - Controversies in the management of community-acquired pneumonia in adults

2024-09-0219:07

E170 - Quality use of medicines: who owns it now?

E170 - Quality use of medicines: who owns it now?

2024-08-2616:47

E169 - Deprescribing antihypertensives in frail older adults

E169 - Deprescribing antihypertensives in frail older adults

2024-08-0520:43

E168 - New and emerging drug therapies for Alzheimer disease

E168 - New and emerging drug therapies for Alzheimer disease

2024-07-2219:22

E167 - Diagnosis and management of obstructive sleep apnoea in adults

E167 - Diagnosis and management of obstructive sleep apnoea in adults

2024-07-0819:45

E166 - Biologic therapies for severe asthma with persistent type 2 inflammation

E166 - Biologic therapies for severe asthma with persistent type 2 inflammation

2024-06-2415:58

E165 - Assessing, communicating and managing cardiovascular disease risk

E165 - Assessing, communicating and managing cardiovascular disease risk

2024-06-1015:50

E164 - Diagnosis and management of eosinophilic oesophagitis

E164 - Diagnosis and management of eosinophilic oesophagitis

2024-05-2717:22

E163 - Managing pre-existing diabetes prior to and during pregnancy

E163 - Managing pre-existing diabetes prior to and during pregnancy

2024-05-1319:07

E162 - Management of menopause symptoms

E162 - Management of menopause symptoms

2024-04-2915:03

E161 - Managing hypercholesterolaemia

E161 - Managing hypercholesterolaemia

2024-04-0821:54

E160 - Ongoing challenges of off-label prescribing

E160 - Ongoing challenges of off-label prescribing

2024-03-2517:37

E159 - Therapeutic Guidelines Dermatology

E159 - Therapeutic Guidelines Dermatology

2024-03-1115:04

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

E165 - Assessing, communicating and managing cardiovascular disease risk

E165 - Assessing, communicating and managing cardiovascular disease risk